How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment
Most SARS-CoV-2 infected patients experience influenza-like symptoms of low or moderate severity. But, already in 2020 early during the pandemic it became obvious that many patients had a high incidence of thrombotic complications, which prompted treatment with high doses of low-molecular-weight hep...
Main Authors: | Bo Nilsson, Barbro Persson, Oskar Eriksson, Karin Fromell, Michael Hultström, Robert Frithiof, Miklos Lipcsey, Markus Huber-Lang, Kristina N. Ekdahl |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.840137/full |
Similar Items
-
How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system
by: Bo Nilsson, et al.
Published: (2023-02-01) -
The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
by: Miklós Lipcsey, et al.
Published: (2021-02-01) -
Blood type A associates with critical COVID-19 and death in a Swedish cohort
by: Michael Hultström, et al.
Published: (2020-08-01) -
Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation—A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients
by: Michael Hultström, et al.
Published: (2022-06-01) -
Plasma Leptin Is Increased in Intensive Care Patients with COVID-19—An Investigation Performed in the PronMed-Cohort
by: Anders Larsson, et al.
Published: (2021-12-01)